CSIMarket Company Name, Ticker, Industry, else..
 
Pelthos Therapeutics Inc   (NYSEAMER: PTHS)
 
Price: $24.2131 $0.13 0.553%
Day's High: $24.68000030517578 Week Perf: -9.59 %
Day's Low: $ 23.73 30 Day Perf: -9.79 %
Volume (M): 9,618 52 Wk High: $ 37.50
Volume (M$): $ 0 52 Wk Avg: $26.68
Open: $23.90 52 Wk Low: $18.19



 Market Capitalization (Millions $) 80
 Shares Outstanding (Millions) 3
 Employees 92
 Revenues (TTM) (Millions $) 28
 Net Income (TTM) (Millions $) -52
 Cash Flow (TTM) (Millions $) 32
 Capital Exp. (TTM) (Millions $) 0

Business Description


Pelthos Therapeutics Inc. is a biopharmaceutical company focused on developing therapeutic products for unmet medical needs. The company has three FDA-approved products, including ZELSUVMI, a topical gel for treating molluscum contagiosum. Pelthos utilizes the NITRICIL technology platform for nitric oxide delivery. The company was formed through the merger of Channel Therapeutics Corporation and LNHC, Inc., and holds commercial, manufacturing, and clinical-stage assets related to its products.


   Company Address: 4020 Stirrup Creek Drive Durham 27703 NC
   Company Phone Number: 908-2400   Stock Exchange / Ticker: NYSEAMER PTHS


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
BCRX        0.92% 
BDTX   -8.93%    
BIIB   -2.14%    
EXEL        0.3% 
GILD        0.77% 
MRNA   -2.87%    
• View Complete Report
   





Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 2.89
Price to Sales (Expected) -
Price to Book 2.28
PEG (TTM) -

Financial Strength Current
Quick Ratio 1.28
Working Capital Ratio 2.79
Leverage Ratio (MRQ) 3.14
Total Debt to Equity 1.41
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -25.29 $
Revenues (TTM) 8.36 $
Cash Flow (TTM) 9.69 $
Cash 9.66 $
Book Value 10.6 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 301,098
Net Income per Employee (TTM) -560,754
Receivable Turnover Ratio (TTM) 3.88
Inventory Turnover Ratio (TTM) 0.32
Asset Turnover Ratio (TTM) 0.28

Profitability Ratios Current
Gross Margin (MRQ) 84.66 %
Operating Margin (MRQ) -120.01 %
Net Margin (MRQ) -93.87 %
Net Cash Flow Margin (MRQ) 130.23 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -



Pelthos Therapeutics Inc's Segments
Commercial operations    97.79 % of total Revenue
Research and Development operations    2.21 % of total Revenue





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.